Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients

Clinical trial NCT04137185 · COMPLETED

Trial details

NCT number: NCT04137185
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Differentiated Thyroid Cancer

Start date: 2019-06-10
Primary completion: 2020-12-29
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.